|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
189 a.a.
|
 |
|
|
|
|
|
|
|
189 a.a.
|
 |
|
|
|
|
|
|
|
330 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lyase
|
 |
|
Title:
|
 |
Complex of gs- with the catalytic domains of mammalian adenylyl cyclase: complex with 2'(3')-o-(n- methylanthraniloyl)-guanosine 5'-triphosphate and mn
|
|
Structure:
|
 |
Adenylate cyclase, type v. Chain: a. Fragment: c1a domain of adenylyl cyclase. Synonym: atp pyrophosphate-lyase, ca2+, -inhibitable adenylyl cyclase. Engineered: yes. Adenylate cyclase, type ii. Chain: b. Fragment: c2a domain of adenylyl cyclase.
|
|
Source:
|
 |
Canis lupus familiaris. Dog. Organism_taxid: 9615. Strain: familiaris. Gene: name=adcy5. Expressed in: escherichia coli bl21. Expression_system_taxid: 511693. Rattus norvegicus. Norway rat.
|
|
Biol. unit:
|
 |
Trimer (from
)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.254
|
R-free:
|
0.298
|
|
|
Authors:
|
 |
T.C.Mou,A.Gille,R.J.Seifert,S.R.Sprang
|
Key ref:
|
 |
T.C.Mou
et al.
(2005).
Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
J Biol Chem,
280,
7253-7261.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
09-Jun-04
|
Release date:
|
14-Dec-04
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P30803
(ADCY5_CANFA) -
Adenylate cyclase type 5
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1265 a.a.
189 a.a.*
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.4.6.1.1
- Adenylate cyclase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP = 3',5'-cyclic AMP + diphosphate
|
 |
 |
 |
 |
 |
ATP
Bound ligand (Het Group name = )
matches with 73.00% similarity
|
=
|
3',5'-cyclic AMP
Bound ligand (Het Group name = )
matches with 68.00% similarity
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Pyridoxal 5'-phosphate
|
 |
 |
 |
 |
 |
Pyridoxal 5'-phosphate
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
5 terms
|
 |
|
Biological process
|
intracellular signal transduction
|
25 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
10 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
280:7253-7261
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for the inhibition of mammalian membrane adenylyl cyclase by 2 '(3')-O-(N-Methylanthraniloyl)-guanosine 5 '-triphosphate.
|
|
T.C.Mou,
A.Gille,
D.A.Fancy,
R.Seifert,
S.R.Sprang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Membrane-bound mammalian adenylyl cyclase (mAC) catalyzes the synthesis of
intracellular cyclic AMP from ATP and is activated by stimulatory G protein
alpha subunits (Galpha(s)) and by forskolin (FSK). mACs are inhibited with high
potency by 2 '(3')-O-(N-methylanthraniloyl) (MANT)-substituted nucleotides. In
this study, the crystal structures of the complex between Galpha(s).GTPgammaS
and the catalytic C1 and C2 domains from type V and type II mAC (VC1.IIC2),
bound to FSK and either MANT-GTP.Mg(2+) or MANT-GTP.Mn(2+) have been determined.
MANT-GTP coordinates two metal ions and occupies the same position in the
catalytic site as P-site inhibitors and substrate analogs. However, the
orientation of the guanine ring is reversed relative to that of the adenine
ring. The MANT fluorophore resides in a hydrophobic pocket at the interface
between the VC1 and IIC2 domains and prevents mAC from undergoing the
"open" to "closed" domain rearrangement. The K(i) of
MANT-GTP for inhibition of VC1.IIC2 is lower in the presence of mAC activators
and lower in the presence of Mn(2+) compared with Mg(2+), indicating that the
inhibitor binds more tightly to the catalytically most active form of the
enzyme. Fluorescence resonance energy transfer-stimulated emission from the MANT
fluorophore upon excitation of Trp-1020 in the MANT-binding pocket of IIC2 is
also stronger in the presence of FSK. Mutational analysis of two non-conserved
amino acids in the MANT-binding pocket suggests that residues outside of the
binding site influence isoform selectivity toward MANT-GTP.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIG. 1. Global and detailed views of G [s]·VC1·IIC2
complex with MANT-GTP. A, complex of G [s]-activated mAC with
MANT-GTP and two Mn2+ ions in the catalytic site. FSK, MANT-GTP,
and two metal ions are bound in the ventral cleft between the C1
and C2 domains. The following coloring scheme is used here and
in Figs. 2 and 3: the VC1 and IIC2 domains are colored tan and
mauve, respectively; the switch II helix of G [s]·GTP S is
shown as a red cylinder; FSK and MANT-GTP are drawn as stick
models; carbon atoms are gray, nitrogen atoms are blue, oxygen
atoms are red, phosphorus atoms are green, and the two Mn2+ ions
are shown as metallic orange spheres. B, substrate-binding site
of VC1·IIC2 showing MANT-GTP and two Mn2+ ions. Secondary
structure elements are labeled as defined previously (16). The
positions of the 1- 1- 2 and 3- 4 of VC1
and 7'- 8' of IIC2 in the mAC
complex with (closed conformation) or without (open
conformation) the competitive inhibitor, -L-2',3'-dd-5'-ATP
(Protein Data Bank codes 1CJU [PDB]
and 1AZS, respectively) (16, 23), were superimposed and depicted
as transparent, rose- and gray-colored elements, respectively.
C, interactions are shown among protein residues, MANT-GTP, and
two metal ions in the VC1·IIC2 substrate-binding site.
MANT-GTP and protein residues are shown as stick models. Stick
models of -L-2',3'-dd-5'-ATP and
selected side chains in Asn-1025 in 1CJU (see A) are shown in
yellow. The gray dashed lines depict the hydrogen bonds between
MANT-GTP and protein residues and coordination of the metal ions
at sites A and B (see text). Because of the high thermal
parameters of the nucleotide (see text), the hydrogen bond
distances are approximate. The coordination between metal ions
and MANT-GTP is similar to that in the complex with -L-2',3'-dd-5'-ATP;
metal A has four ligands, whereas metal B has five ligands. D,
detailed view of the purine-binding pocket in the mAC
substrate-binding site (see text) The superimposed adenosine
group of -L-2',3'-dd-5'-ATP is
shown in yellow. The distances of hydrogen bond between guanine
ring and surrounding protein residues are as indicated.
|
 |
Figure 2.
FIG. 2. Difference electron density for
3·-O-MANT-GTP in complex with G [s]·VC1·IIC2.
The complexes formed in the presence with Mn2+ or Mg2+ are shown
in A and B, respectively. The blue wire cage corresponds to
|F[o]| - |F[c]| electron density contoured at 2.5 .
Coordinates for MANT-GTP and the two metal ions were omitted
from the phasing model.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2005,
280,
7253-7261)
copyright 2005.
|
|
| |
Figures were
selected
by the author.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Erdorf,
and
R.Seifert
(2011).
Pharmacological characterization of adenylyl cyclase isoforms in rabbit kidney membranes.
|
| |
Naunyn Schmiedebergs Arch Pharmacol, 383,
357-372.
|
 |
|
|
|
|
 |
M.Hübner,
S.Dizayee,
J.Matthes,
R.Seifert,
and
S.Herzig
(2011).
Effect of MANT-nucleotides on L-type calcium currents in murine cardiomyocytes.
|
| |
Naunyn Schmiedebergs Arch Pharmacol, 383,
573-583.
|
 |
|
|
|
|
 |
M.T.Mazhab-Jafari,
C.B.Marshall,
M.Smith,
G.M.Gasmi-Seabrook,
V.Stambolic,
R.Rottapel,
B.G.Neel,
and
M.Ikura
(2010).
Real-time NMR study of three small GTPases reveals that fluorescent 2'(3')-O-(N-methylanthraniloyl)-tagged nucleotides alter hydrolysis and exchange kinetics.
|
| |
J Biol Chem, 285,
5132-5136.
|
 |
|
|
|
|
 |
B.Pavan,
C.Biondi,
and
A.Dalpiaz
(2009).
Adenylyl cyclases as innovative therapeutic goals.
|
| |
Drug Discov Today, 14,
982-991.
|
 |
|
|
|
|
 |
C.Pinto,
M.Hübner,
A.Gille,
M.Richter,
T.C.Mou,
S.R.Sprang,
and
R.Seifert
(2009).
Differential interactions of the catalytic subunits of adenylyl cyclase with forskolin analogs.
|
| |
Biochem Pharmacol, 78,
62-69.
|
 |
|
|
|
|
 |
H.M.Taha,
J.Schmidt,
M.Göttle,
S.Suryanarayana,
Y.Shen,
W.J.Tang,
A.Gille,
J.Geduhn,
B.König,
S.Dove,
and
R.Seifert
(2009).
Molecular analysis of the interaction of anthrax adenylyl cyclase toxin, edema factor, with 2'(3')-O-(N-(methyl)anthraniloyl)-substituted purine and pyrimidine nucleotides.
|
| |
Mol Pharmacol, 75,
693-703.
|
 |
|
|
|
|
 |
S.Pierre,
T.Eschenhagen,
G.Geisslinger,
and
K.Scholich
(2009).
Capturing adenylyl cyclases as potential drug targets.
|
| |
Nat Rev Drug Discov, 8,
321-335.
|
 |
|
|
|
|
 |
S.Suryanarayana,
J.L.Wang,
M.Richter,
Y.Shen,
W.J.Tang,
G.H.Lushington,
and
R.Seifert
(2009).
Distinct interactions of 2'- and 3'-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor.
|
| |
Biochem Pharmacol, 78,
224-230.
|
 |
|
|
|
|
 |
S.Suryanarayana,
M.Göttle,
M.Hübner,
A.Gille,
T.C.Mou,
S.R.Sprang,
M.Richter,
and
R.Seifert
(2009).
Differential inhibition of various adenylyl cyclase isoforms and soluble guanylyl cyclase by 2',3'-O-(2,4,6-trinitrophenyl)-substituted nucleoside 5'-triphosphates.
|
| |
J Pharmacol Exp Ther, 330,
687-695.
|
 |
|
|
|
|
 |
T.C.Mou,
N.Masada,
D.M.Cooper,
and
S.R.Sprang
(2009).
Structural basis for inhibition of mammalian adenylyl cyclase by calcium.
|
| |
Biochemistry, 48,
3387-3397.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.Schlicker,
A.Rauch,
K.C.Hess,
B.Kachholz,
L.R.Levin,
J.Buck,
and
C.Steegborn
(2008).
Structure-based development of novel adenylyl cyclase inhibitors.
|
| |
J Med Chem, 51,
4456-4464.
|
 |
|
|
|
|
 |
J.L.Wang,
J.X.Guo,
Q.Y.Zhang,
J.J.Wu,
R.Seifert,
and
G.H.Lushington
(2007).
A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.
|
| |
Bioorg Med Chem, 15,
2993-3002.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
| |